Table 3.
CAS | Chemicals | Structure | Clinical application | Anti-aging activity and proposed anti-aging mechanism |
---|---|---|---|---|
With anti-aging activities in a variety of aging models | ||||
58-08-2 | Caffeine | Psychoactive drug | In rats: antioxidant, alleviating neuroinflammation and neurodegeneration [75] In zebrafish: 29.4% increase in mean lifespan and regulating proteostasis [74] In C. elegans: 29.4% increase in mean lifespan and regulating IIS pathway and proteostasis [73] |
|
657-24-9 | Metformin | Treatment of type 2 diabetes and polycystic ovary syndrome | In rats: altering erythrocyte redox status [70] In D. melanogaster: has not effect on fecundity or lifespan and activating AMPK, reducing lipid stores [72] In C. elegans: 40.0% increase in mean lifespan and regulating AMPK, LKB1, and SKN-1 [71] |
|
53123-88-9 | Rapamycin | Used to coat coronary stents, prevent organ transplant rejection and to treat a rare lung disease called lymphangioleiomyomatosis | In mice: 14.0% increase in mean lifespan for females and 9% for males and reducing mTOR activity [76–82] In D. melanogaster: 13.0% increase in mean lifespan and regulating TORC1 branch of the TOR pathway, through alterations to both autophagy and translation [83] In C. elegans: 19.0% increase in mean lifespan and regulating TOR, SKN-1 and DAF-16 [84] |
|
With anti-aging activities in two aging models | ||||
50-78-2 | Aspirin | Used to treat pain, fever, and inflammation | In genetically heterogeneous male mice: 8.0% increase in mean lifespan and needs further research [135] In C. elegans: 30.0% increase in mean lifespan and antioxidant, regulating AMPK and insulin-like signaling pathway [183, 308] |
|
2086-83-1 | Berberine | Used to treat bacillary dysentery and gastroenteritis | In aged mice: suppressing neuroinflammation, reducing vascular stiffness in aged mice through suppression of TRPV4 [309, 310] In D. melanogaster: 46.0% increase in mean lifespan and inhibiting kynurenine (KYN) formation from tryptophan (TRP) [311] |
|
102518-79-6 | Huperzine A | Treatment for neurological conditions such as Alzheimer’s disease | In d-galactose-induced mice: inhibiting DAMPs-mediated NF-κB nuclear localization and activation [312] In C. elegans: 14.0% increase in mean lifespan and needs further research [285] |
|
10118-90-8 | Minocycline | Antibiotic | In D. melanogaster: 63.0% increase in mean lifespan and antioxidant [313] In C. elegans: 29.0% increase in mean lifespan and antioxidant [176] |
|
114-86-3 | Phenformin | Antidiabetic | In mice: 21.0% increase in mean lifespan and decreasing the body weight, slowing down the age-related decline of the reproductive function in female rats [314] In C. elegans: 29.0% increase in mean lifespan and needs further research [315] |
|
59-02-9 | Vitamin E | Vitamins | In rats: reducing the oxidative stress increased in old age [316, 317] In C. elegans: 23.0% increase in mean lifespan and antioxidant [318] |
|
With anti-aging activities in rats or mice | ||||
692-13-7 | Buformin | Antidiabetic | In rats: 7.0% increase in mean lifespan in female and decreasing the body weight, slowing down the age-related decline of the reproductive function in female rats [314] | |
73-31-4 | Melatonin | Regulating sleep and wakefulness | In male Wistar: restoring rSocs1 rhythms and levels in various tissues [319] | |
155974-00-8 | Ivabradine | Used for the symptomatic management of stable heart related chest pain and heart failure | In C57BL/6 J mice: 6.0% increase in mean lifespan and reducing heart rate [320] | |
56180-94-0 | Acarbose | Antidiabetic | In SAMP8 mice and male mice: 22.0% increase in mean lifespan and changing in the insulin system and the levels of BDNF, IGF-1R, and the pre-synaptic proteins Syt1 and Stx1 [321, 322] | |
51384-51-1 | Metoprolol | Used to treat high blood pressure, chest pain due to poor blood flow to the heart, and a number of conditions involving an abnormally fast heart rate | In mice: 10.0% increase in mean lifespan and needs further research [323] | |
99200-09-6 | Nebivolol | Treatment of hypertension | In mice: 6.4% increase in mean lifespan and needs further research [323] | |
With anti-aging activities in Drosophila melanogaster | ||||
13123-37-0 | Riboflavin | Vitamin | 14.1% increase in mean lifespan and increasing SOD1 and CAT, inhibiting LF [324] | |
84057-84-1 | Lamotrigine | Anticonvulsant | 17.0% increase in mean lifespan and reducing locomotor activity and metabolic rate [325] | |
1716-12-7 | 4-Phenyl-butyrate | Used to treat urea cycle disorder | 40.0% increase in mean lifespan and increasing histone acetylation [326] | |
52757-95-6 | Sevelamer | Used to treat hyperphosphatemia in patients with chronic kidney disease | 16.0% increase in mean lifespan and regulating cellular and organismic phosphate levels [327] | |
79902-63-9 | Simvastatin | Hypolipidemic | 25.0% increase in mean lifespan and decreasing specific protein prenylation [328] | |
871700-17-3 | Trametinib | Anti-cancer | 12.0% increase in mean lifespan and inhibiting Ras-Erk-ETS signaling [329] | |
58880-19-6 | Trichostatin A | Antifungal antibiotic | 27.0% increase in mean lifespan and changing the level of histone acetylation, influencing the expression of hsp22 gene [330] | |
57-27-2 | Morphine | Treatment of acute pain and chronic pain | 22.0% increase in mean lifespan and needs further research [331] | |
With anti-aging activities in Caenorhabditis elegans | ||||
14028-44-5 | Amoxapine | Antidepressant | 33.0% increase in mean lifespan and antioxidant [176] | |
298-57-7 | Cinnarizine | Treatment of vertigo, motion sickness, and vomiting | 15.0% increase in mean lifespan and antioxidant [176] | |
59865-13-3 | Cyclosporin A | Immunosuppressants | 18.0% increase in mean lifespan and antioxidant [176] | |
427-51-0 | Cyproterone acetate | Antiandrogen and progestogen | 23.0% increase in mean lifespan and antioxidant [176] | |
17230-88-5 | Danazol | Treatment of endometriosis | 13.0% increase in mean lifespan and antioxidant [176] | |
127-33-3 | Demeclocycline hydrochloride | Antibiotic | 16.0% increase in mean lifespan and antioxidant [176] | |
564-25-0 | Doxycycline | Antibiotic | 18.0% increase in mean lifespan and antioxidant [176] | |
10592-13-9 | Doxycycline hydrochloride | Antibiotic | 18.0% increase in mean lifespan and antioxidant [176] | |
119431-25-3 | Eliprodil | NMDA antagonist, treatment of acute ischemic stroke | 16.0% increase in mean lifespan and antioxidant [176] | |
23256-50-0 | Guanabenz acetate | Antihypertensive | 12.0% increase in mean lifespan and antioxidant [176] | |
29110-48-3 | Guanfacine hydrochloride | Treatment of hyperactivity | 15.0% increase in mean lifespan and antioxidant [176] | |
27833-64-3 | Loxapine succinate | Antipsychotic | 43.0% increase in mean lifespan and antioxidant [176] | |
57149-08-3 | Naftopidil di-hydrochloride | Antihypertensive | 14.0% increase in mean lifespan and antioxidant [176] | |
54527-84-3 | Nicardipine hydrochloride | Used to treat high blood pressure and angina | 23.0% increase in mean lifespan and antioxidant [176] | |
39562-70-4 | Nitrendipine | Used in the treatment of primary (essential) hypertension to decrease blood pressure and can reduce the cardiotoxicity of cocaine | 25.0% increase in mean lifespan and antioxidant [176] | |
894-71-3 | Nortriptyline hydrochloride | Tricyclic antidepressant | 21.0% increase in mean lifespan and antioxidant [176] | |
60607-34-3 | Oxatomide | Anti-allergic | 25.0% increase in mean lifespan and antioxidant [176] | |
130-61-0 | Thioridazine hydrochloride | Antipsychotic | 31.0% increase in mean lifespan and antioxidant [176] | |
2068-78-2 | Vincristine sulfate | Anti-cancer | 12.0% increase in mean lifespan and antioxidant [176] | |
97-59-6 | Allantoin | Used to treat gastric ulcer, duodenal bulb ulcer, chronic gastritis | 21.9% increase in mean lifespan and caloric restriction mimetics [332] | |
169590-42-5 | Celecoxib | COX-2 selective nonsteroidal anti-inflammatory drug (NSAID) It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain | 19.0% increase in mean lifespan and inhibiting insulin-like signaling [333] | |
99-66-1 | Valproic acid | Used to treat epilepsy and bipolar disorder and to prevent migraine headaches | 35.0% increase in mean lifespan and regulating IIS pathway [334] | |
103-90-2 | Acetaminophen | Used to treat pain and fever | 49.0% increase in mean lifespan and regulating CBP-1 [224] | |
69-52-3 | Ampicillin | Antibiotic | 34.0% increase in mean lifespan and antimicrobial [284] | |
41859-67-0 | Bezafibrate | Treatment of hypertriglyceridemia | 13.0% increase in mean lifespan and regulating NHR-49/PPARalpha-dependent manner [335] | |
637-07-0 | Clofibrate | Lipid-lowering agent used for controlling the high cholesterol and triacylglyceride level in the blood | 16.0% increase in mean lifespan and regulating NHR-49/PPARalpha-dependent manner [335] | |
49562-28-9 | Fenofibrate | Used to reduce cholesterol levels in people at risk of cardiovascular disease | 19.0% increase in mean lifespan and regulating NHR-49/PPARalpha-dependent manner [335] | |
127-48-0 | Trimethadione | Anticonvulsant | 47.0% increase in mean lifespan and regulating neuromuscular activity [336] | |
42971-09-5 | Vinpocetine | Treatment of cerebrovascular disorders and age-related memory impairment | 15.0% increase in mean lifespan and regulating PDE1 [176] | |
59-30-3 | Folic acid | Used to treat anemia caused by folic acid deficiency | 27.0% increase in mean lifespan and antioxidant, regulating SIR-2.1, SKN-1, and DAF-16 [337] | |
77-67-8 | Ethosuximide | Used to treat absence seizures | 17.0% increase in mean lifespan and disrupting sensory function, regulating DAF-16 [336, 338, 339] | |
50264-69-2 | Lonidamine | Anti-cancer | 8.0% increase in mean lifespan and promoting longevity in a pmk-1sensitive manner by increasing formation of ROS [340] | |
50-55-5 | Reserpine | Antipsychotic, and antihypertensive | 31.0% increase in mean lifespan and antioxidant, modulating acetylcholine release [341, 342] | |
13292-46-1 | Rifampicin | Antibiotic | 56.0% increase in mean lifespan and reducing advanced glycation end products and activating DAF-16 [343] | |
6998-60-3 | Rifamycin SV | Antibiotic | 21.0% increase in mean lifespan and reducing advanced glycation end products and activating DAF-16 [343] | |
723-46-6 | Sulfa-methoxazole | Antibiotic | 34.0% increase in mean lifespan and increasing lipid peroxidation oxidative stress [344] | |
56-75-7 | Chloram-phenicol | Antibiotic | 16.0% increase in mean lifespan and needs further research [345] | |
With anti-aging activities in other aging models | ||||
53-06-5 | Cortisone | Used to reduce inflammation and attendant pain and swelling at the site of the injury | In Asplanchna brightwelli: 21.0% increase in mean lifespan and stabilizing lysosomal membranes, or altering resource allocation by the rotifers [346] | |
35891-70-4 | Myriocin | Antibiotic ISP-1 and thermozymocidin | In S. cerevisiae: activating the Snf1/AMPK pathway, down-regulating the protein kinase A (PKA) and target of rapamycin complex 1 (TORC1) pathways [347] |